Johnson & Johnson Trading Volume Plummets 43.2% to 111th in Daily Rankings Amid Stock Price Decline

On June 17, 2025, Johnson & Johnson (JNJ) experienced a significant drop in trading volume, with a 43.2% decrease from the previous day, totaling 6.19 billion. This decline placed JNJ at the 111th position in the daily stock market rankings. The stock price of JNJ fell by 1.83%, marking the second consecutive day of decline, with a total decrease of 3.01% over the past two days.

Johnson & Johnson has recently launched the TECNIS Odyssey Next-Generation Intraocular Lens (IOL) in Europe, the Middle East, and Canada. This new IOL is designed to provide patients with precise vision at all distances and in various lighting conditions. The lens offers high-quality and continuous vision, allowing patients to see clearly from far to near, which is a significant advancement in cataract treatment.

This launch is part of Johnson & Johnson's ongoing commitment to innovation in the field of ophthalmology. The TECNIS Odyssey IOL is expected to improve the quality of life for cataract patients by reducing their dependence on glasses. The new IOL enables 93% of patients to become free from glasses at all distances, thanks to its best-in-class image contrast and low-light performance.